Hillsdale Investment Management’s Gilead Sciences GILD Stock Holding History

Hillsdale Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Sell	8,400 -300	-3%	-$42K	0.03%	343
2025 Q4	$1.07M	Sell	8,700 -1,200	-12%	-$146K	0.03%	352
2025 Q3	$1.1M	Buy	9,900 +1,600	+19%	+$182K	0.03%	340
2025 Q2	$920K	Sell	8,300 -500	-6%	-$53.2K	0.03%	317
2025 Q1	$986K	Hold	8,800	–	–	0.05%	252
2024 Q4	$813K	Buy	+8,800	New	+$792K	0.04%	271
2024 Q3	–	Sell	-9,430	Closed	-$647K	–	647
2024 Q2	$647K	Buy	9,430 +9,270	+5,794%	+$619K	0.05%	255
2024 Q1	$11.7K	Hold	160	–	–	﹤0.01%	479
2023 Q4	$13K	Sell	160 -404	-72%	-$31.4K	﹤0.01%	451
2023 Q3	$42.3K	Sell	564 -7,826	-93%	-$602K	﹤0.01%	427
2023 Q2	$647K	Buy	8,390 +460	+6%	+$36.7K	0.06%	203
2023 Q1	$658K	Buy	7,930 +1,630	+26%	+$135K	0.06%	255
2022 Q4	$541K	Sell	6,300 -2,200	-26%	-$174K	0.05%	307
2022 Q3	$524K	Hold	8,500	–	–	0.05%	310
2022 Q2	$525K	Buy	+8,500	New	+$526K	0.04%	325
2021 Q3	–	Sell	-95	Closed	-$7K	–	591
2021 Q2	$7K	Sell	95 -6,475	-99%	-$432K	﹤0.01%	554
2021 Q1	$425K	Buy	6,570 +100	+2%	+$6.45K	0.04%	379
2020 Q4	$377K	Sell	6,470 -530	-8%	-$32K	0.04%	373
2020 Q3	$443K	Hold	7,000	–	–	0.04%	349
2020 Q2	$539K	Hold	7,000	–	–	0.05%	303
2020 Q1	$524K	Sell	7,000 -1,105	-14%	-$76.4K	0.06%	286
2019 Q4	$526K	Buy	8,105 +200	+3%	+$13K	0.05%	337
2019 Q3	$501K	Buy	7,905 +335	+4%	+$21.9K	0.04%	345
2019 Q2	$512K	Buy	7,570 +900	+13%	+$59.2K	0.05%	328
2019 Q1	$434K	Buy	6,670 +2,080	+45%	+$138K	0.04%	350
2018 Q4	$287K	Sell	4,590 -700	-13%	-$48.9K	0.03%	378
2018 Q3	$408K	Hold	5,290	–	–	0.05%	224
2018 Q2	$375K	Sell	5,290 -20	-0.4%	-$1.41K	0.05%	255
2018 Q1	$400K	Sell	5,310 -200	-4%	-$15.9K	0.06%	213
2017 Q4	$395K	Hold	5,510	–	–	0.06%	245
2017 Q3	$447K	Buy	5,510 +700	+15%	+$53.5K	0.08%	195
2017 Q2	$341K	Buy	4,810 +10	+0.2%	+$665	0.07%	225
2017 Q1	$326K	Hold	4,800	–	–	0.06%	220
2016 Q4	$343K	Hold	4,800	–	–	0.07%	206
2016 Q3	$380K	Hold	4,800	–	–	0.1%	202
2016 Q2	$400K	Buy	4,800 +200	+4%	+$17.7K	0.12%	160
2016 Q1	$422K	Buy	4,600 +600	+15%	+$54.1K	0.14%	129
2015 Q4	$405K	Hold	4,000	–	–	0.15%	134
2015 Q3	$393K	Hold	4,000	–	–	0.13%	141
2015 Q2	$468K	Hold	4,000	–	–	0.14%	130
2015 Q1	$393K	Buy	4,000 +800	+25%	+$81.2K	0.1%	172
2014 Q4	$302K	Sell	3,200 -200	-6%	-$20.7K	0.08%	237
2014 Q3	$362K	Sell	3,400 -200	-6%	-$19.6K	0.12%	137
2014 Q2	$298K	Buy	3,600 +500	+16%	+$38.9K	0.07%	217
2014 Q1	$220K	Buy	+3,100	New	+$243K	0.06%	295

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hillsdale Investment Management's GILD Position: Q1 2026 in Review

Hillsdale Investment Management reduced its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, selling an estimated $42K and leaving 8,400 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #343.

Hillsdale Investment Management first reported a position in GILD in Q1 2014 and has held it in 45 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Hillsdale Investment Management held 8,400 shares of Gilead Sciences worth $1.17M as of Q1 2026.
Hillsdale Investment Management sold 300 Gilead Sciences shares in Q1 2026, an estimated $42K.
Gilead Sciences made up 0.03% of Hillsdale Investment Management's portfolio in Q1 2026, its #343 holding.
Hillsdale Investment Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 45 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.